发明名称 |
Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease |
摘要 |
A FcgammaRIIa transgenic non-human animal model for autoimmune disease, particularly arthritis. This invention also provides a method of using this model to screen compounds that can reduce aberrant immune activity including aberrant immune complex formation aberrant immune complex clearance and immune complex induced inflammation. This invention also provides means of using this model to treat or prevent autoimmune disease.
|
申请公布号 |
NZ536963(A) |
申请公布日期 |
2008.04.30 |
申请号 |
NZ20030536963 |
申请日期 |
2003.06.06 |
申请人 |
TRILLIUM THERAPEUTICS INC |
发明人 |
HOGARTH, PHILLIP MARK;MOTTRAM, PATRICIA LESLEY;SARDJONO, CAROLINE TAN |
分类号 |
A01K67/027;A61K45/00;A61P1/04;A61P19/02;A61P29/00;A61P37/02;A61P43/00;C07K14/735;C12N15/09;C12N15/12;C12N15/85;C12Q1/02;G01N33/15;G01N33/50;(IPC1-7):C12N15/85;C07K14/705 |
主分类号 |
A01K67/027 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|